Search research articles
Contact Us
Filters
Showing results (181-190 of 858) with videos related to
Page
of 86
Sort By:
The American Journal of Cardiology
|
May 29, 2002
Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period
Robert A Kloner, Ken Poole, Thomas Shook, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 12, 2009
Identification of genetic variants associated with response to statin therapy
Jessica L Mega, David A Morrow, Alison Brown, et al.
The American Journal of Cardiology
|
October 3, 2002
Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction
Sabina A Murphy, Christopher Chen, Christopher P Cannon, et al.
American Heart Journal
|
January 31, 2006
Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study
Eric E Smith, Christopher P Cannon, Sabina Murphy, et al.
Journal of Clinical Lipidology
|
October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)
James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
Journal of the American College of Cardiology
|
August 1, 2006
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
Christopher P Cannon, Benjamin A Steinberg, Sabina A Murphy, et al.
Clinical Cardiology
|
December 29, 2017
The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22
Dylan L Steen, Amarachi A Umez-Eronini, Jianping Guo, et al.
The American Journal of Cardiology
|
October 11, 2018
WITHDRAWN: Raising the Bar by Lowering the Target: Integrating PCSK9 Inhibitors Into Hypercholesterolemia Management
Christie M Ballantyne, Deepak L Bhatt, Christopher P Cannon, et al.
Critical Pathways in Cardiology
|
February 17, 2012
Are continuing medical education activities effective in improving the competence and performance of clinicians? Evidence from activities for primary care clinicians who manage patients with acute coronary syndromes
Janardhan Sampath, Derek T Dietze, Peter P Toth, et al.
Journal of the American College of Cardiology
|
January 20, 2010
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial
Sabina A Murphy, Christopher P Cannon, Stephen D Wiviott, et al.
Page
of 86
Search research articles
Search
Showing results (181-190 of 858) with videos related to
Sort By:
Page
of 86
The American Journal of Cardiology
|
May 29, 2002
Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period
Robert A Kloner, Ken Poole, Thomas Shook, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 12, 2009
Identification of genetic variants associated with response to statin therapy
Jessica L Mega, David A Morrow, Alison Brown, et al.
The American Journal of Cardiology
|
October 3, 2002
Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction
Sabina A Murphy, Christopher Chen, Christopher P Cannon, et al.
American Heart Journal
|
January 31, 2006
Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study
Eric E Smith, Christopher P Cannon, Sabina Murphy, et al.
Journal of Clinical Lipidology
|
October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)
James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
Journal of the American College of Cardiology
|
August 1, 2006
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
Christopher P Cannon, Benjamin A Steinberg, Sabina A Murphy, et al.
Clinical Cardiology
|
December 29, 2017
The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22
Dylan L Steen, Amarachi A Umez-Eronini, Jianping Guo, et al.
The American Journal of Cardiology
|
October 11, 2018
WITHDRAWN: Raising the Bar by Lowering the Target: Integrating PCSK9 Inhibitors Into Hypercholesterolemia Management
Christie M Ballantyne, Deepak L Bhatt, Christopher P Cannon, et al.
Critical Pathways in Cardiology
|
February 17, 2012
Are continuing medical education activities effective in improving the competence and performance of clinicians? Evidence from activities for primary care clinicians who manage patients with acute coronary syndromes
Janardhan Sampath, Derek T Dietze, Peter P Toth, et al.
Journal of the American College of Cardiology
|
January 20, 2010
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial
Sabina A Murphy, Christopher P Cannon, Stephen D Wiviott, et al.
Page
of 86